Abstract:Objective To investigate the effect of bortezomib on proliferation and apoptosis of pancreatic cancer cell lines BxPC3,SW1990 and explore possible mechanisms of bortezomib's killing effect on cancer cells.Methods BxPC3,SW1990 cells were treated by using 1,10,50,100,500 nmol/L and 1,10 μmol/L of bortezomib,and cells without bortezomib treatment were considered as control group.The cell proliferation was determined by MTF assay,and apoptosis was determined by flow cytometry.Bak,Bax,Bcl2,Bcl-xl,survivin mRNA expressions were measured by RT-PCR,and Western blot was applied to determine the expressions of pro-caspase-3,cleaved-caspase-3,Bax,Bcl-2,surviving protein.Results When bortezomib concentration was higher than 50 nmol/L,it inhibited the proliferation of two cell lines in a dose and time-dependent manner.And with the same treatment the rate of proliferation inhibition of BxPC3 cells by bortezomib was greater than that of SW1990 cells,and the difference between the two cell lines was statistically significant (P ＜0.05).Apoptosis rates in the groups of BxPC-3 and SW1990 cells treated by 100 nmol/L bortezomib were (22.56 ± 4.23) ％ and (12.71 ± 2.23) ％,which were significantly higher than those in control group (2.15 ± 0.47) ％ and (2.32 ± 0.54) ％,P ＜ 0.05).In addition,apoptosis rate of BxPC3 cells was significantly higher than that of SW1990 cells (P＜0.05).Bak mRNA expression of BxPC3 and SW1990 cells after 100 nmol/L bortezomib treatment were not significantly changed,but the expression of Bax mRNA and protein was significantly increased (P ＜0.05).Bcl-2 mRNA and protein,as well as Bcl-xl mRNA expressions was significantly decreased (P ＜0.05).The expression of survivin mRNA and protein in BxPC3 cells were decreased,but were increased in SW1990 cells(P ＜0.05).The expression of pro-caspase-3 protein in the two cell lines was decreased,while the expression of cleaved-caspase-3 protein was increased (P ＜0.05).Conclusions Bortezomib can inhibit the proliferation of pancreatic cancer cell Iines BxPC-3 and SW1990 and induce apoptosis,and the effect on BxPC3 cells is more than that on SW1990 cells.The mechanism may depend on activation of the mitochondrial pathway of apoptosis,and be related to survivin-involved drug-resistance.

Study on Effects of Bortezomib on Expression of ICAM-1 of K562 Cells

[Effects of Proteasome Inhibitor Bortezomib on NF-kappaB Activity and ICAM-1 Mrna Expression of K562 Cells].

[Apoptosis in Jurkat Cells Induced by Bortezomib Combined with Adriamycin].

Overcoming Acquired TRAIL Resistance in Human Colon Cancer by Proteasome Inhibitor Bortezomib

The Effect of Bortezomib on Migration of Endothelial Cells and Angiogenesis

[Effect of Bortezomib on VEGF Gene Expression of Endothelial Cell Line HMEC-1 and Its Possible Mechanisms].

Effects of bortezomib on growth inhibition of pancreatic cancer cells BxPC3 and SW1990 in vitro

Study on the effects of proteasome inhibitor PS-341 on apoptosis and expression of cytokines of U266 cells

[Inducing-Apoptosis Effect of Bortezomib on Acute Monocytic Leukemia Cell SHI-1 and Its Influence on Expressions of Bcl2l12, Bcl-2 and Bax Genes].

Effect of Bortezomib on Heparanase Expression and Migration Ability of Multiple Myeloma Cells

Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells.

Bortezomib increases cytotoxic sensitivity of drug-resistant K562 /ADM cells to NK cells and its mechanisms

Effect of Bortezomib on Global Gene Expression in PC12-Derived Nerve Cells

Effects of Different Concentrations of Bortezomib on the Expression of NF-κB, IκB and P-gp of DNR-resistant K562 Cells

[Bortezomib-Induced BiP Expression and Apoptosis in Multiple Myeloma Cells].

Genome-Wide Profiling of the Toxic Effect of Bortezomib on Human Esophageal Carcinoma Epithelial Cells.

[Effect of VE-cadherin on sensitivity to Imatinib in Sup-B15 Philadelphia chromosome positive acute lymphoblastic leukemia cells].

[Effect of Bortezomib and Low Concentration Cytarabine on Apoptosis in U937 Cell Line].

Effects of xbp-1 gene silencing on bortezomib-induced apoptosis in human multiple myeloma cells]

Bortezomib Potentiates Antitumor Activity of Mitoxantrone Through Dampening Wnt/β-catenin Signal Pathway in Prostate Cancer Cells

The Increased NK Cell-Mediated Cytotoxicity in Human Hepatocellular Carcinoma by Low-Dose Proteasome Inhibitor Bortezomib Through NKG2D Pathway